Watson introduces generic version of Concerta
Links shared publicly online about this topic.
- 323total visits
Watson introduces generic version of Concerta
View full resource at news-medical.net
Tags: ADHD Medication, Pharma, Concerta, Watson Pharmaceuticals
Most Recently Shared on May 2, 2011 at 1:32 pm By:
Medicare News: Watson introduces generic version of Concerta: Watson Pharmaceuticals, Inc. today confirmed that ... http://bit.ly/m6YkgS
Also Shared By:
Watson launches a generic of ADHD drug Concerta - AAP SmartBrief
smartbrief.com — “Watson Laboratories began selling methylphenidate hydrochloride, an extended-release drug for attention-deficit/hyperactivity disorder in patients ages 6 to 65. It is a generic version of Ortho-McNeil-Janssen Pharmaceuticals' Concerta. ” View full resource at smartbrief.com
Most Recently Shared on May 4, 2011 at 9:13 pm By:
Watson launches a generic of ADHD drug Concerta - AAP SmartBrief http://fb.me/WWouxsPJ
Watson introduces Famciclovir tablets to treat cold sores, genital herpes
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application by the U.S. Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on March 22, 2011 at 7:42 am By:
Medicare News: Watson introduces Famciclovir tablets to treat cold sores, genital herpes: Watson Pharmaceuticals... http://bit.ly/hap2Zf
Watson nabs authorized-generic deal with J&J - FiercePharma
fiercepharma.com — “Watson Pharmaceuticals ($WPI) and Johnson & Johnson ($JNJ) have come to an accord on Concerta. J&J will let Watson launch a generic version of the blockbuster ADHD drug next May, as long as... Read more...” View full resource at fiercepharma.com
Most Recently Shared on November 3, 2010 at 4:21 pm By:
Watson nabs authorized-generic deal with J&J http://bit.ly/bfQ40k #ADHD
Watson enters exclusive agreement with OMJPI to market authorized generic Concerta
news-medical.net — “Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), to market the authorized generic version of Concerta® (methylphenidate hydrochloride extended-release tablets). Watson will launch its authorized generic of Concerta on May 1, 2011. Concerta is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).” View full resource at news-medical.net
Most Recently Shared on November 2, 2010 at 12:45 pm By:
Watson enters exclusive agreement with OMJPI to market authorized generic Concerta: Watson Pharmaceuticals, Inc. t... http://bit.ly/bGwzwI
Advertisement


News-Medical.Net
@NewsMedical
Watson enters exclusive agreement with OMJPI to market authorized generic Concerta: Watson Pharmaceuticals, Inc. t... http://bit.ly/bGwzwI
1 year ago...